Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases
expected for 2040. Despite de advances in the treatment, it remains a challenge because of …

Cancer is still a major threat to human life that is characterized by abnormal proliferation and
metastasis of cancer cells. Chemotherapy is procedure of using anti-cancer drugs for …

RNAi is a remarkable treatment strategy to knock down gene overexpression in a variety of
disorders, including cancers. RNAi processes allow siRNAs to detect and degrade a …

To improve liposomes' usage as drug delivery vehicles, cryoprotectants can be utilized to
prevent constituent leakage and liposome instability. Cryoprotective agents (CPAs) or …

The site-specific delivery of drugs, especially anti-cancer drugs has been an interesting field
for researchers and the reason is low accumulation of cytotoxic drugs in cancer cells …

The increasing prevalence of cancer drug resistance not only critically limits the efficiency of
traditional therapies but also causes relapses or recurrences of cancer. Consequently, there …

In this study, the impact of different delivery systems on the cytokine-inducing,
antiproliferative, and antitumor activities of short immunostimulatory double-stranded RNA …

Simple Summary Current approaches to the treatment of oncological diseases are still
suffering from a lack of efficiency and selectivity and are accompanied by pronounced non …

Given the pharmacophore properties of the nitrogen-containing moiety in the molecular
structure of P-glycoprotein (P-gp) inhibitors, we report the evaluation of the P-gp inhibitory …

Different therapeutic practices for treating cancers have significantly evolved to compensate
and/or overcome the failures in conventional methodologies. The demonstrated potentiality …